HIV remission hope: Antibody-Vaccine combo aims to replace daily pills
NCT ID NCT06484335
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This study tests whether a combination of lab-made antibodies and a therapeutic vaccine can help people with HIV control the virus without daily antiretroviral therapy. About 48 adults who started HIV treatment very early (during acute infection) will receive the antibodies and vaccine or a placebo. The goal is to see if this approach is safe and can keep the virus at bay during a temporary pause in their regular medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Faculty of Medicine, Chulalongkorn University/ King Chulalongkorn Memorial Hospital
RECRUITINGPathum Wan, Bangkok, 10330, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.